Top > Search of International Patents > Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins

Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins

Foreign code F110005216
File No. A202-04WO
Posted date Aug 26, 2011
Country United States of America
Application number 19846208
Gazette No. 20090075388
Gazette No. 8022173
Date of filing Aug 26, 2008
Gazette Date Mar 19, 2009
Gazette Date Sep 20, 2011
Priority data
  • P2006-050926 (Feb 27, 2006) JP
  • 2007WO-JP53593 (Feb 27, 2007) WO
Title Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins
Abstract (US8022173)
The present invention herein provides a combination of stable isotope-labeled aliphatic amino acids, which permits the structural analysis of a high molecular weight protein, in particular, a high molecular weight protein whose molecular weight exceeds 60 kDa.
This is a combination of stable isotope-labeled amino acids which is characterized in that arginine (Arg), glutamine (Gln), glutamic acid (Glu), lysine (Lys), methionine (Met) and proline (Pro) satisfy the following requirements concerning the labelling pattern: (b) one of the methylene hydrogen atoms of at least one of the methylene groups is deuterated and the both of the two methylene hydrogen atoms of at least one of the methylene groups are likewise deuterated; and (d) when they each have a methyl group, the hydrogen atoms of the methyl group except for one of the same are deuterated, or the methyl group is completely deuterated.
Scope of claims [claim1]
1. A composition of stable isotope-labeled amino acids wherein all of the aliphatic amino acids constituting a target protein satisfy the following requirements concerning the labeling pattern: (a) When only one methylene group carrying two hydrogen atoms exists, one of the methylene hydrogen atoms is deuterated;
(b) When at least two methylene groups each carrying two hydrogen atoms exist, one of the methylene hydrogen atoms of at least one of the methylene groups is deuterated and the both of the two methylene hydrogen atoms of at least one of the methylene groups are likewise deuterated;
(c) When pro-chiral gem-methyl groups exist, all of the hydrogen atoms on one of the methyl groups are completely deuterated while the hydrogen atoms on the other methyl groups are partially deuterated;
(d) When a further methyl group in addition to the foregoing ones exists, the methyl group is partially deuterated, or the methyl group is completely deuterated; and
(e) side chain methine hydrogen atoms are deuterated;
wherein the aliphatic amino acids are selected from the group consisting of arginine, glutamine, glutamic acid, isoleucine, leucine, lysine, methionine, proline, threonine and valine; and
wherein the isotope is selected from carbon, hydrogen, and nitrogen.
[claim2]
2. A composition of stable isotope-labeled amino acids in which arginine (Arg), glutamine (Gln), glutamic acid (Glu), lysine (Lys), methionine (Met) and proline (Pro) constituting a target protein satisfy the following requirements concerning the labeling pattern: (b) one of the methylene hydrogen atoms of at least one of the methylene groups is deuterated and the both of the two methylene hydrogen atoms of at least one of the methylene groups are likewise deuterated; and
(d) when they each have a methyl group, the methyl group is partially deuterated, or the methyl group is completely deuterated; and
wherein the isotope is selected from carbon, hydrogen, and nitrogen.
[claim3]
3. The composition of stable isotope-labeled amino acids as set forth in claim 1, wherein (f) after the deuteration, all of the carbon atoms of methylene groups and/or methyl groups each carrying hydrogen atoms are replaced with 13C atoms.
[claim4]
4. The composition of stable isotope-labeled amino acids as set forth in claim 1, wherein (g) the carbon atoms of the completely deuterated methylene groups are replaced with 13C and/or 12C.
[claim5]
5. The composition of stable isotope-labeled amino acids as set forth in claim 1, wherein (h) the carbon atoms of the completely deuterated methylene groups are replaced with 12C.
[claim6]
6. The composition of stable isotope-labeled amino acids as set forth in claim 2, wherein all of the carbon atoms present in the amino acids are 13C atoms.
[claim7]
7. The composition of stable isotope-labeled amino acids as set forth in claim 2, wherein one of the hydrogen atoms present on the methylene group at beta -position is deuterated.
[claim8]
8. The composition of stable isotope-labeled amino acids as set forth in claim 1, wherein the amino acid in which one methylene group carrying two hydrogen atom is present or which is free of any such a methylene group is isoleucine (Ile), valine (Val), threonine (Thr), or leucine (Leu) and the methine groups situating at the beta -positions of isoleucine (Ile) and valine (Val) and that situating at gamma -position of leucine (Leu) are deuterated.
[claim9]
9. The composition of stable isotope-labeled amino acids as set forth in claim 1, wherein the carbon atoms of the methine groups situating at the beta -positions of isoleucine (Ile), valine (Val) and threonine (Thr) and that situating at gamma -position of leucine (Leu) are 12C atoms.
[claim10]
10. The composition of stable isotope-labeled amino acids as set forth in claim 1, wherein the nitrogen atoms constituting the amino acids are completely or partially replaced with 15N.
[claim11]
11. The composition of stable isotope-labeled amino acids as set forth in claim 1, wherein the isotope-labeled amino acids are those represented by the following formulas (1) to (13):
wherein, in these formulas, the carbon atoms are 12C or 13C atoms; the nitrogen atoms are 14N or 15N atoms; H represents a hydrogen atom; and D represents a deuterium atom.
[claim12]
12. A composition of stable isotope-labeled amino acids constituting a target protein wherein the aliphatic amino acids constituting the target protein are stable isotope-labeled aliphatic amino acids as set forth in claim 1 and wherein the aromatic amino acids constituting the target protein are selected from following stable isotope-labeled aromatic amino acids: A stable isotope-labeled phenylalanine, in which the carbon atom of a phenyl group attached to an amino acid residue represented by the following formula A is 13C atom; 2 to 4 carbon atoms out of the remaining 5 carbon atoms constituting the phenyl group are 12C atoms, each of which is combined with a deuterium atom; and the remaining carbon atoms of the phenyl group are 13C atoms, each of which is combined with a hydrogen atom;
A stable isotope-labeled tyrosine, in which the carbon atom of a phenyl group attached to an amino acid residue represented by the following formula A is 13C atom; the carbon atom combined with the hydroxyl group (OH group) present on the phenyl group is a 12C atom or a 13C atom; 2 to 4 carbon atoms out of the remaining 4 carbon atoms constituting the phenyl group are 12C atoms, each of which is combined with a deuterium atom; and the remaining carbon atoms of the phenyl group are 13C atoms, each of which is combined with a hydrogen atom;
A stable isotope-labeled tryptophane, in which the carbon atom of an indolyl group attached to an amino acid residue represented by the following formula A is 13C atom; 1 to 5 carbon atoms out of the remaining 7 carbon atoms constituting the indolyl group are 12C atoms, each of which is combined with a deuterium atom; the remaining carbon atoms of the indolyl group are 13C atoms, each of which is combined with a hydrogen atom; and the nitrogen atom of the NH group constituting the indolyl group is a 15N atom or a 14N atom; and
A stable isotope-labeled histidine, in which the carbon atom of an imidazolyl group attached to an amino acid residue represented by the following formula A is 13C atom; the both of the remaining 2 carbon atoms constituting the imidazolyl group are 13C atoms, which are each combined with a hydrogen atom, or one of the carbon atoms is a 13C atom which is combined with a deuterium atom and the other carbon atom is a 13C atom which is combined with a hydrogen atom; one of the two nitrogen atoms constituting the imidazolyl group is a 15N atom and the other thereof is a 14N atom; and the hydrogen atom constituting the NH group is not a deuterium atom:
-- *1C(X)(Y) -- *2C(Z)(15NH)(*3COOH) (A)
wherein each of *1C, *2C, and *3C represents 12C or 13C; X, Y and Z each represent a hydrogen atom or a deuterium atom.
  • Inventor, and Inventor/Applicant
  • KAINOSHO MASATSUNE
  • TERAUCHI TSUTOMU
  • JAPAN SCIENCE AND TECHNOLOGY AGENCY
IPC(International Patent Classification)
Reference ( R and D project ) CREST Understanding the Brain (Mechanisms of Brain) AREA
Please contact us by E-mail or facsimile if you have any interests on this patent.

PAGE TOP

close
close
close
close
close
close